{"schemaVersion":"peptidescanner-peptide-evidence-feed/v1","canonicalUrl":"https://peptidescanner.com/feeds/peptides/thymosin-alpha-1.json","peptide":{"slug":"thymosin-alpha-1","name":"Thymosin alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"},"release":{"label":"Beta · 17 Nov 2026","reviewedAt":"2026-11-17"},"entryCount":48,"entries":[{"objectId":"story:clinicaltrials-gov-nct00001036-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00001036","domain":"Clinical trials","dateInSource":"2008-07-30","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00001036-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct00001036-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct00001036-thymosin-alpha-1-v1","contentSha256":"b1584e6b0b4638394a3392031c55b75c09d872408b16123157a5308376479a63"},{"objectId":"story:clinicaltrials-gov-nct00711620-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00711620","domain":"Clinical trials","dateInSource":"2011-06-14","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00711620-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct00711620-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct00711620-thymosin-alpha-1-v1","contentSha256":"d74464e1fd8a8b6cdce3d88ef496906606f0154cdac99779b5e37946148621f9"},{"objectId":"story:clinicaltrials-gov-nct00911443-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00911443","domain":"Clinical trials","dateInSource":"2009-07-09","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00911443-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct00911443-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct00911443-thymosin-alpha-1-v1","contentSha256":"66e9e146693895d56a006d85aec6f3fb3ddb6727fb2f18249ea286a11780203d"},{"objectId":"story:clinicaltrials-gov-nct01031966-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01031966","domain":"Clinical trials","dateInSource":"2012-03-29","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01031966-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct01031966-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct01031966-thymosin-alpha-1-v1","contentSha256":"089f6f7d8b0d98f78111f97a482c14aa746621ccd06e3e33b317c5bf753df049"},{"objectId":"story:clinicaltrials-gov-nct01178996-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01178996","domain":"Clinical trials","dateInSource":"2010-08-10","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01178996-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct01178996-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct01178996-thymosin-alpha-1-v1","contentSha256":"2c002511edfb714083a805dd18e6615af27e02d1fe0d77f8e1e7e6d96d8233f9"},{"objectId":"story:clinicaltrials-gov-nct02473406-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT02473406","domain":"Clinical trials","dateInSource":"2021-04-05","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02473406-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct02473406-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct02473406-thymosin-alpha-1-v1","contentSha256":"9182c1012c5448e844f9594c5f510cfbf3c62f8c11b28dec4547350b30836ace"},{"objectId":"story:clinicaltrials-gov-nct02646189-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT02646189","domain":"Clinical trials","dateInSource":"2016-01-05","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02646189-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct02646189-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct02646189-thymosin-alpha-1-v1","contentSha256":"f31dc53f9301a4f40dd43dd676418dfa13bfaf37eb5ac5783cca347614be1e2a"},{"objectId":"story:clinicaltrials-gov-nct02867267-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT02867267","domain":"Clinical trials","dateInSource":"2023-04-10","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02867267-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct02867267-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct02867267-thymosin-alpha-1-v1","contentSha256":"d0e602446e2ec1d874423af4864423d8a77dbe65dba327c90c95679261def169"},{"objectId":"story:clinicaltrials-gov-nct02883595-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT02883595","domain":"Clinical trials","dateInSource":"2019-04-04","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02883595-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct02883595-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct02883595-thymosin-alpha-1-v1","contentSha256":"508ef05d09f353734dd51d550e32faed7775a468093bfb690c492eb0b73d8e96"},{"objectId":"story:clinicaltrials-gov-nct03659578-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT03659578","domain":"Clinical trials","dateInSource":"2022-01-03","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03659578-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct03659578-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct03659578-thymosin-alpha-1-v1","contentSha256":"dc5b8896f8af88d38d1151d1ac62930554cb29510260537679e3427b6b78b991"},{"objectId":"story:clinicaltrials-gov-nct04428008-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT04428008","domain":"Clinical trials","dateInSource":"2026-04-21","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04428008-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct04428008-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct04428008-thymosin-alpha-1-v1","contentSha256":"95208c27599d5931e45edd8e5cb831adc77686ea4a15f5d8a81137a565a4dac5"},{"objectId":"story:clinicaltrials-gov-nct05086614-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT05086614","domain":"Clinical trials","dateInSource":"2021-10-21","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05086614-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct05086614-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct05086614-thymosin-alpha-1-v1","contentSha256":"d3e955c5dc3415bf9fca2e228253871ba5e685fffdd718cb60c0e8e5ef68a730"},{"objectId":"story:clinicaltrials-gov-nct06024356-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT06024356","domain":"Clinical trials","dateInSource":"2026-06-18","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06024356-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct06024356-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct06024356-thymosin-alpha-1-v1","contentSha256":"d9dae2610f260145af363e77f60aa938e7017bd2f3de012b0a27823aad19b362"},{"objectId":"story:clinicaltrials-gov-nct06139419-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT06139419","domain":"Clinical trials","dateInSource":"2026-08-03","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06139419-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct06139419-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct06139419-thymosin-alpha-1-v1","contentSha256":"1ac334f5a0ecfb48be3ac24b79711ec0038573f844b60789cf9e56ac3a41ea6d"},{"objectId":"story:clinicaltrials-gov-nct06461910-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT06461910","domain":"Clinical trials","dateInSource":"2026-03-03","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06461910-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct06461910-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct06461910-thymosin-alpha-1-v1","contentSha256":"91a60b21b1fb748d492acfde05a9886632d9004cbe4ca813f962f6973f517e65"},{"objectId":"story:clinicaltrials-gov-nct07780721-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT07780721","domain":"Clinical trials","dateInSource":"2026-08-21","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07780721-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct07780721-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct07780721-thymosin-alpha-1-v1","contentSha256":"e34ca6a34433f828fe4f26fbdb9f83b642aa0a1ecc9d193a2743bc735825cbb4"},{"objectId":"story:clinicaltrials-gov-nct07884201-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT07884201","domain":"Clinical trials","dateInSource":"2026-10-20","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07884201-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct07884201-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct07884201-thymosin-alpha-1-v1","contentSha256":"747e1f6c298cd610c13f332d5581e66154719729353330a7f4ba7babd69d5f84"},{"objectId":"story:clinicaltrials-gov-nct07922954-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT07922954","domain":"Clinical trials","dateInSource":"2026-11-06","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07922954-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct07922954-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct07922954-thymosin-alpha-1-v1","contentSha256":"18c6a257d4ec7a2410e3cef1f2e10788dfa56779cadfa1ed332d11696797ae34"},{"objectId":"story:pubmed-pmid-11381492-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"Thymosin alpha-1.","domain":"Literature metadata","dateInSource":"2019-02-22","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-11381492-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-11381492-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-11381492-thymosin-alpha-1-v1","contentSha256":"533afdb9fe9d863176233dab8a2a726953a8228283f8df87b4882aabc7655a94"},{"objectId":"story:pubmed-pmid-12860169-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"Thymosin alpha(1) in combination with cytokines and chemotherapy for the treatment of cancer.","domain":"Literature metadata","dateInSource":"2018-11-30","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-12860169-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-12860169-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-12860169-thymosin-alpha-1-v1","contentSha256":"9ac6e6a1d22f88eef289200952279e8294fc16cf823e80de0b5086903e1c3ec5"},{"objectId":"story:pubmed-pmid-15482167-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"Thymalfasin for the treatment of chronic hepatitis B.","domain":"Literature metadata","dateInSource":"2019-11-09","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-15482167-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-15482167-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-15482167-thymosin-alpha-1-v1","contentSha256":"4353927f2ca3a199c982b5478abca89692adb56e0045f02620b66b567174f7f5"},{"objectId":"story:pubmed-pmid-15546255-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"Combination therapy of thymalfasin (thymosin-alpha 1) and peginterferon alfa-2a in patients with chronic hepatitis C virus infection who are non-responders to standard treatment.","domain":"Literature metadata","dateInSource":"2026-01-28","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-15546255-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-15546255-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-15546255-thymosin-alpha-1-v1","contentSha256":"074b46d9d0086029d53b63a629466b392413050c6b4b38c37ede2b958b249cbd"},{"objectId":"story:pubmed-pmid-15641208-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B.","domain":"Literature metadata","dateInSource":"2018-12-01","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-15641208-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-15641208-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-15641208-thymosin-alpha-1-v1","contentSha256":"5214f4aacba0d149428f4c570f0c6d8b58d586bff4e8bbb63ecbe1c1293194f4"},{"objectId":"story:pubmed-pmid-15641209-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"Combination therapy of thymalfasin (thymosin-alpha 1) and peginterferon alfa-2a in patients with chronic hepatitis C virus infection who are non-responders to standard treatment.","domain":"Literature metadata","dateInSource":"2018-12-01","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-15641209-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-15641209-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-15641209-thymosin-alpha-1-v1","contentSha256":"e87b59cab7e7275a5fd01d1ba5d2450de0dc857e7b839afe941197272a044db5"},{"objectId":"story:pubmed-pmid-16307501-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"Thymalfasin for the treatment of chronic hepatitis C infection.","domain":"Literature metadata","dateInSource":"2018-12-03","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-16307501-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-16307501-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-16307501-thymosin-alpha-1-v1","contentSha256":"7775df9959c74352ec2d4611e824ba1a16fe247f2ef7220b94634b34425e1bcb"},{"objectId":"story:pubmed-pmid-17600281-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"Thymosin alpha 1 as an adjunct to influenza vaccination in the elderly: rationale and trial summaries.","domain":"Literature metadata","dateInSource":"2018-12-01","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-17600281-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-17600281-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-17600281-thymosin-alpha-1-v1","contentSha256":"b5d5cd81b0f5b29a343dca8ebf649d58c95ff02022028b31bbb03f9ec0c91afd"},{"objectId":"story:pubmed-pmid-18410608-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot study.","domain":"Literature metadata","dateInSource":"2018-12-01","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-18410608-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-18410608-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-18410608-thymosin-alpha-1-v1","contentSha256":"fc4058edf5bc95b30e5c9e0cdc8e2a96c96b01703163c4afaeb507521dc616f9"},{"objectId":"story:pubmed-pmid-19033321-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"A new immunomodulatory therapy for severe sepsis: Ulinastatin Plus Thymosin {alpha} 1.","domain":"Literature metadata","dateInSource":"2018-12-01","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-19033321-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-19033321-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-19033321-thymosin-alpha-1-v1","contentSha256":"5a9d0b077b3d07d4d7ece6d7e9731713b934683ae37788eeedd05ee388655c96"},{"objectId":"story:pubmed-pmid-19392576-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"From lab to bedside: emerging clinical applications of thymosin alpha 1.","domain":"Literature metadata","dateInSource":"2022-03-16","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-19392576-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-19392576-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-19392576-thymosin-alpha-1-v1","contentSha256":"1e2b2963e4a6dbbe18af6567b83a50d3cfb3251a9d8a35a5a9b6e32824e475ae"},{"objectId":"story:pubmed-pmid-19467157-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis.","domain":"Literature metadata","dateInSource":"2024-05-16","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-19467157-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-19467157-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-19467157-thymosin-alpha-1-v1","contentSha256":"29d72004eab4ecc560429f230ea308e72f5f1c2e9f229a645cc6e88f54703511"},{"objectId":"story:pubmed-pmid-20194853-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"Large randomized study of thymosin alpha 1, interferon alfa, or both in combination with dacarbazine in patients with metastatic melanoma.","domain":"Literature metadata","dateInSource":"2025-04-28","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-20194853-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-20194853-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-20194853-thymosin-alpha-1-v1","contentSha256":"ec89e4416ec91454ce54601445256701a3466612718326c2e2d8d91e9df9ceb7"},{"objectId":"story:pubmed-pmid-20536445-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1.","domain":"Literature metadata","dateInSource":"2018-12-01","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-20536445-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-20536445-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-20536445-thymosin-alpha-1-v1","contentSha256":"ce4457f3f4766fd1c9e7833f7ca560d1bff67118def1f797b667ec98d001a7b9"},{"objectId":"story:pubmed-pmid-20536460-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"Thymosin alpha 1: past clinical experience and future promise.","domain":"Literature metadata","dateInSource":"2026-01-28","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-20536460-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-20536460-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-20536460-thymosin-alpha-1-v1","contentSha256":"23a90c8381d64aa595449f48de5eca423f7fe6b2a6a1eebfbc6746b916d092f7"},{"objectId":"story:pubmed-pmid-20536461-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"Thymosin alpha 1 for treatment of hepatitis C virus: promise and proof.","domain":"Literature metadata","dateInSource":"2018-12-01","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-20536461-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-20536461-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-20536461-thymosin-alpha-1-v1","contentSha256":"ff58de5c6366a76173e3c0ea03d2b0187cfc7c14ee6b64aa98bfb09a5d252cc7"},{"objectId":"story:pubmed-pmid-20536462-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"Thymalfasin in the treatment of hepatitis B and C.","domain":"Literature metadata","dateInSource":"2026-01-28","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-20536462-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-20536462-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-20536462-thymosin-alpha-1-v1","contentSha256":"8b9a3e05e272caf7cbf2938a320a043bbb3d13cc1c62c2f5ba389ef20854d900"},{"objectId":"story:pubmed-pmid-21272455-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"[Treatment with interferon and thymosin alpha-1 versus interferon monotherapy for HBeAg positive chronic hepatitis B: a meta-analysis].","domain":"Literature metadata","dateInSource":"2018-12-01","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-21272455-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-21272455-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-21272455-thymosin-alpha-1-v1","contentSha256":"32d41965cf74a4431aac9df53c06f67d59887e52663ae744ba2b63aefdf16c2c"},{"objectId":"story:pubmed-pmid-22010537-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"Utility of thymosin alpha-1 (Zadaxin) as a co-adjuvant in influenza vaccines: a review.","domain":"Literature metadata","dateInSource":"2018-12-01","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-22010537-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-22010537-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-22010537-thymosin-alpha-1-v1","contentSha256":"f86dd190e2b26b04136b2872b612603401cdd7be771d6d46612bcf9283f4d9a1"},{"objectId":"story:pubmed-pmid-22233415-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"Thymosin alpha-1 with peginterferon alfa-2a/ribavirin for chronic hepatitis C not responsive to IFN/ribavirin: an adjuvant role?","domain":"Literature metadata","dateInSource":"2018-12-01","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-22233415-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-22233415-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-22233415-thymosin-alpha-1-v1","contentSha256":"2effd1b924983893d749e72a2a91834316560856c4d69ab3765ba09853369caf"},{"objectId":"story:pubmed-pmid-28106477-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"Thymosin alpha 1 and HIV-1: recent advances and future perspectives.","domain":"Literature metadata","dateInSource":"2018-12-02","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-28106477-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-28106477-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-28106477-thymosin-alpha-1-v1","contentSha256":"a50875b8b3545e740d78bf71dec64a605f825de292592c2ae73f5ae207f61587"},{"objectId":"story:pubmed-pmid-30063860-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label study.","domain":"Literature metadata","dateInSource":"2019-01-11","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-30063860-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-30063860-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-30063860-thymosin-alpha-1-v1","contentSha256":"5181762db5f38490b95fb022f7bb499754050174370b1c086990f1a5a8ac9bb5"},{"objectId":"story:pubmed-pmid-30063864-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"Serum thymosin alpha 1 levels in normal and pathological conditions.","domain":"Literature metadata","dateInSource":"2019-06-25","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-30063864-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-30063864-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-30063864-thymosin-alpha-1-v1","contentSha256":"ba48fd951ea1e7fc1e6a169615fe5fcdfb089908bb89a8d97fbadd091197a24c"},{"objectId":"story:pubmed-pmid-30063866-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"Thymosin alpha 1 treatment for patients with sepsis.","domain":"Literature metadata","dateInSource":"2019-06-25","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-30063866-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-30063866-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-30063866-thymosin-alpha-1-v1","contentSha256":"512abd2779360063a3f0a74a9b81ad51064266a37e6fc7ceb9de3a4a6fb00391"},{"objectId":"story:pubmed-pmid-33362999-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"Thymosin alpha 1: A comprehensive review of the literature.","domain":"Literature metadata","dateInSource":"2020-12-29","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-33362999-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-33362999-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-33362999-thymosin-alpha-1-v1","contentSha256":"c69d50c8110ecd9822c06a0e4ebbdd082ed5d2af2a17eaa8ad9c4080736d3bda"},{"objectId":"story:pubmed-pmid-38903817-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"Phenotypic drug discovery: a case for thymosin alpha-1.","domain":"Literature metadata","dateInSource":"2024-06-22","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-38903817-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-38903817-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-38903817-thymosin-alpha-1-v1","contentSha256":"971cf04737d068ad6ff282284bc31fba4532dad0a6b30556ef7ac1a9bd40b223"},{"objectId":"story:pubmed-pmid-39648386-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"Thymosin Alpha 1 Plus Routine Treatment for the Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.","domain":"Literature metadata","dateInSource":"2024-12-16","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-39648386-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-39648386-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-39648386-thymosin-alpha-1-v1","contentSha256":"bcba6c5a557bb416f1cdfcda869de6ae8ec3780a9af0d1ebaac8929a54efe99b"},{"objectId":"story:pubmed-pmid-41373628-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"Aging and Thymosin Alpha-1.","domain":"Literature metadata","dateInSource":"2025-12-14","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-41373628-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-41373628-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-41373628-thymosin-alpha-1-v1","contentSha256":"6517c4d45db77169760b526ae693f5950d368c2777d8fa8168dcf390a6dfa836"},{"objectId":"story:pubmed-pmid-41749205-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"Neoadjuvant immunochemotherapy plus thymalfasin in locally advanced gastric cancer: a prospective clinical trial.","domain":"Literature metadata","dateInSource":"2026-09-14","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-41749205-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-41749205-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-41749205-thymosin-alpha-1-v1","contentSha256":"ffae1b2e185e36a365192045015afa0eb45a6d294f7eb267ed92cf7fa0a1c857"},{"objectId":"story:pubmed-pmid-42797537-thymosin-alpha-1:v1","state":"current","stateChangedAt":"2026-11-15","title":"Clinical Applications and Evidence Landscape of Thymosin Alpha 1 as an Immunomodulatory Adjunct in Cancer Care: A Scoping Review.","domain":"Literature metadata","dateInSource":"2026-09-29","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42797537-thymosin-alpha-1/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-42797537-thymosin-alpha-1-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-42797537-thymosin-alpha-1-v1","contentSha256":"dd9ff7f53f8b5ca2b57684275d4d79980ba8935dd5ad9e664cae16dbc1d25d01"}]}
